Navigation Links
Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis
Date:5/8/2012

of death.

While the exact cause of RA is unknown, the Caton laboratory and others have shown that a variety of white blood cells called regulatory T cells (or Tregs) are a necessary component to either restrain (or encourage) the immune system's inflammatory response. Tregs are activated as molecules on their surface membranes called T cell receptors interact with "friendly" or "self" moleculesa way for the immune system to recognize friend from foe. Mismanagement of these Tregs, which normally serve to restrain the immune system from over-reacting to healthy tissue, could then lead to runaway inflammation.

In this study, the researchers sought to examine how T cell receptors affect the ability of Tregs to suppress arthritis in a mouse that had been bred to express a "self" molecule that drives arthritis. They showed that an array of Tregs given to the mice effectively stops arthritis. Unexpectedly, however, Tregs that are specific for the surrogate "self" molecule do not prevent arthritis.

"We find that the Treg responsible for recognition of the disease-initiating self antigen are sufficient for stopping arthritis, but a diverse repertoire of Tregs are very effective," Caton said. "All of these Tregs, together, influence other components of the immune system which serves to slow down the inflammatory process that causes RA."

According to Caton, their findings also point to a possible answer of why the immune system targets the membranes that line joints. Tregs influence other types of T cells to produce a substance known as IL-17, and these cells often travel through the body's lymphatic system where they then drain out into the joints.

"The big unanswered question of RA is 'why are joints targeted?'" Caton said. "Of all the tissues in the body, of all the places our immune system could attack, this question remains."

"One idea is that the immune system isn't deliberately attacking joints in patients with rhe
'/>"/>

Contact: Greg Lester
glester@wistar.org
215-898-3943
The Wistar Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Regulatory enzyme overexpression may protect against neurodegeneration in Huntingtons disease
2. Moffitt Cancer Center researchers find regulatory T-cell clue to help prevent GVHD
3. FDA awards Georgetown University a Center of Excellence in Regulatory Science & Innovation
4. Key regulatory genes often amplified in aggressive childhood tumor of the brainstem
5. FDA should invest in developing a new regulatory framework to replace flawed 510(k) medical device clearance process
6. Specialized regulatory T cell stifles antibody production centers
7. Newly discovered regulatory mechanism essential for embryo development and may contribute to cancer
8. “Global Supply Chain Visibility and Security; Business Necessity, Regulatory Imperative”
9. RAPS Seeks Nominations for Regulatory Awards, RAPS Fellows
10. iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives
11. NIH-FDA Joint Briefing on Regulatory Science Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30, 2014 Daily Gossip reveals in its ... Him Desire You program, who shows a unique formula to ... of this method says that the program goes beyond mere ... Him Desire You review indicates that the program was created ... and his great techniques to make a man feel emotionally ...
(Date:8/30/2014)... 30, 2014 The term nutraceuticals ... Pharameuticals. Nutraceuticals is a source of healthy-dietary supplements ... natural food sources. Nutraceutical ingredients have certain curative ... human body. Nutraceutical health products include factors such ... and more. Although nature is the most bountiful ...
(Date:8/30/2014)... Tenn. (PRWEB) August 30, 2014 ... around the country for the past several years, ... Tennessee Hyperbaric Center have announced a scholarship program ... This announcement follows a meeting held this summer ... In recent years, reporters have shed light on ...
(Date:8/30/2014)... York, New York (PRWEB) August 30, 2014 ... other incretin mimetic claims continue to move forward in ... statement issued by AstraZeneca PLC on July 31, 2014, ... been named in 409 product liability claims that allege ... Court documents indicate that many of these claims are ...
(Date:8/30/2014)... 30, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
Breaking Medicine News(10 mins):Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... Teens who eat less salt lower their long-term risk for high ... finding stems from a computerized projection of what would happen if ... salt from their daily consumption of common processed foods. "Reducing ... that we eat could mean that teenagers live many more years ...
... , SATURDAY, Nov. 13 (HealthDay News) -- People who ... increased risk themselves for the potentially deadly heart rhythm ... data from 4,421 participants in the long-term Framingham Heart ... start of the study. Between 1968 and 2007, 440 ...
... say that physicians might be drawing conclusions too soon ... whose bodies were for a day initially chilled into ... as therapeutic hypothermia, is one of the few medical ... stoppages, with brain recovery usually assessed three days after ...
... HealthDay Reporter , FRIDAY, Nov. 12 (HealthDay News) -- ... have made significant discoveries in the past year that might ... disease in its tracks. That,s some good ... in 1991 as a joint project between the International Diabetes ...
... Northwestern Memorial Hospital recently implanted a patient with two ... available for study in humans. VADs are designed to ... or both (BiVAD) at once. This is the first ... the left and right ventricles anywhere in North Americaa ...
... (HealthDay News) -- A minor gene variation may be associated with ... study has found. In a recent experiment, Martin Reuter, of ... with this variation in a gene known as COMT gave away ... people with another variation of the gene. The COMT gene ...
Cached Medicine News:Health News:Study Urges Teens to Cut Down on Salt 2Health News:Study suggests physicians wait longer for brain recovery after hypothermia Rx in cardiac arrest 2Health News:Study suggests physicians wait longer for brain recovery after hypothermia Rx in cardiac arrest 3Health News:Diabetes Research Made Significant Strides in Past Year 2Health News:Diabetes Research Made Significant Strides in Past Year 3Health News:Small assist device used in emergency case as twin, heart booster pumps for first time in US 2
(Date:8/30/2014)... , Aug. 30, 2014  Boston Scientific ... NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical ... trial investigating vagus nerve stimulation (VNS) for the ... Ph.D., Professor of Therapeutics and Cardiology and Director ... National de la Sante et de la Recherche ...
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  ... Affiniti, a new ultrasound system designed to ... demands of increasing patient volumes and cost pressures. Making ... 2014 in Barcelona this ... facing more patients with fewer resources deliver high quality ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market survey ... industry . The report firstly reviews the basic ... application and manufacturing technology. The report then explores ... Scanner listing their product specification, capacity, Production value, ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... SAN DIEGO, Dec. 21, 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ... President and Chief Executive Officer, will host a conference call ... Eastern Time (5:30 a.m. Pacific Time) to provide an update ... Food and Drug Administration (FDA) for the lorcaserin New Drug ...
... YORK, Dec. 21, 2010 Reportlinker.com announces that ... its catalogue: U.S. Preclinical ... http://www.reportlinker.com/p0350308/US-Preclinical-Animal-Imaging-Systems-Market.html This research ... Animal Imaging Systems Market since 2006. It examines ...
Cached Medicine Technology:Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 2Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 3
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic and i...
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
Medicine Products: